Back
Oppenheimer Holdings 10K Form
Buy
73
OPY
Oppenheimer Holdings
Last Price:
$61.17
Seasonality Move:
5.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-26 | 10Q | OPY/Oppenheimer Holdings Quarterly |
2024-03-01 | 10K | OPY/Oppenheimer Holdings Annual |
2023-10-27 | 10Q | OPY/Oppenheimer Holdings Quarterly |
2023-07-28 | 10Q | OPY/Oppenheimer Holdings Quarterly |
2023-04-28 | 10Q | OPY/Oppenheimer Holdings Quarterly |
2023-03-03 | 10K | OPY/Oppenheimer Holdings Annual |
Receive OPY News And Ratings
See the #1 stock for the next 7 days that we like better than OPY
OPY Financial Statistics
Sales & Book Value
Annual Sales: | $1.4B |
---|---|
Cash Flow: | $-93.4M |
Price / Cash Flow: | 0 |
Annual Sales: | $82.87 |
Price / Book: | 0.72 |
Profitability
EPS (TTM): | 6.72000 |
---|---|
Net Income (TTM): | $76.2M |
Gross Margin: | $468M |
Return on Equity: | 9.12% |
Return on Assets: | 2.26% |
Oppenheimer Holdings Earnings Forecast
Key Oppenheimer Holdings Financial Ratios
-
The Gross Profit Margin over the past 15 years for OPY is 32.67%.
-
The Selling, General & Administrative Expenses for OPY have been equal to 11.39% of Gross Profit Margin.
-
The Interest Expense is 122.97% of Operating Income.
-
The Net Earning history of OPY is 5.00% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 23 years.
Oppenheimer Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | OPY |
CUSIP: | 683797 |
Website: | oppenheimer.com |
Debt
Debt-to-Equity Ratio: | 0.83 |
---|---|
Current Ratio: | 4.12 |
Quick Ratio: | 3.9 |
Price-to-Earnings
Trailing P/E Ratio: | 9.42 |
---|---|
Forward P/E Ratio: | 0 |
OPY Technical Analysis vs Fundamental Analysis
Buy
73
Oppenheimer Holdings (OPY)
is a Buy
Is Oppenheimer Holdings a Buy or a Sell?
-
Oppenheimer Holdings stock is rated a BuyThe current Oppenheimer Holdings [OPY] share price is $61.16. The Score for OPY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.